• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A simulation model of the cost of the incidence of IDDM in Spain.

作者信息

Hart W M, Espinosa C, Rovira J

机构信息

SOIKOS, Barcelona, Spain.

出版信息

Diabetologia. 1997 Mar;40(3):311-8. doi: 10.1007/s001250050680.

DOI:10.1007/s001250050680
PMID:9084970
Abstract

This study estimates the direct health care costs of the incidence of insulin-dependent diabetes mellitus (IDDM) in Spain. A discrete event simulation model was developed to approximate the natural history of a cohort of newly diagnosed patients in a given year and used to calculate the average costs which would accumulate during the lifetime of the group of patients. The model takes into account both the underlying costs of control and maintenance of the disease plus the additional costs of long-term complications that are likely to develop as the disease progresses. The model is based on national and international epidemiological and demographic information combined with local cost data. The number of newly diagnosed cases of IDDM each year, based on Spanish epidemiological data, was calculated to be approximately 1791 cases in 1994. The baseline results from the model indicate that the average life expectancy of an IDDM patient is approximately 59.6 years with an average lifetime cost of 12.7 million pesetas per individual (1994 undiscounted values), 5.1 million pesetas per individual when discounted at a rate of 6% and 8060 million pesetas for the entire newly diagnosed cohort discounted at a rate of 6%. Sensitivity analysis was undertaken in order to observe the effect on the result of changes in the values of key variables.

摘要

相似文献

1
A simulation model of the cost of the incidence of IDDM in Spain.
Diabetologia. 1997 Mar;40(3):311-8. doi: 10.1007/s001250050680.
2
[Costs of known diabetes mellitus in Spain].[西班牙已知糖尿病的成本]
Med Clin (Barc). 1997 Sep 13;109(8):289-93.
3
Disease progression and cost of insulin dependent diabetes mellitus: development and application of a simulation model.胰岛素依赖型糖尿病的疾病进展与成本:模拟模型的开发与应用
J Soc Health Syst. 1998;5(4):24-37.
4
[Insulin-dependent diabetes in the county of Funen 1970-2020. An epidemiological description].[1970 - 2020年菲英岛县胰岛素依赖型糖尿病。一项流行病学描述]
Ugeskr Laeger. 1998 Feb 16;160(8):1163-7.
5
Empiric investigation on direct costs-of-illness and healthcare utilization of Medicaid patients with diabetes mellitus.对医疗补助计划糖尿病患者疾病直接成本和医疗保健利用情况的实证调查。
Am J Manag Care. 1998 Oct;4(10):1433-46.
6
[Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].[全科医生报告的糖尿病患病率、抗糖尿病治疗及慢性糖尿病并发症情况]
Przegl Lek. 2005;62(4):201-5.
7
Epidemiology of complications and total treatment costs from diagnosis of Type 2 diabetes in Germany (ROSSO 4).德国2型糖尿病确诊后的并发症流行病学及总治疗成本(ROSSO 4)。
Exp Clin Endocrinol Diabetes. 2007 Sep;115(8):495-501. doi: 10.1055/s-2007-981470.
8
Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain.澳大利亚、加拿大、法国、德国、意大利和西班牙糖尿病并发症成本综述。
Curr Med Res Opin. 2005 Oct;21(10):1617-29. doi: 10.1185/030079905X65349.
9
The cost-effectiveness of different management strategies for type I diabetes: a Swiss perspective.I型糖尿病不同管理策略的成本效益:瑞士视角
Diabetologia. 2000 Jan;43(1):13-26. doi: 10.1007/s001250050003.
10
The cost of insulin-dependent diabetes mellitus (IDDM) in England and Wales.英格兰和威尔士胰岛素依赖型糖尿病(IDDM)的成本。
Diabet Med. 1995 Dec;12(12):1068-76. doi: 10.1111/j.1464-5491.1995.tb00423.x.

引用本文的文献

1
Diabetes: cost of illness in Norway.糖尿病:挪威的疾病负担。
BMC Endocr Disord. 2010 Sep 20;10:15. doi: 10.1186/1472-6823-10-15.
2
Cost of severe hypoglycaemia in patients with type 1 diabetes in Spain and the cost-effectiveness of insulin lispro compared with regular human insulin in preventing severe hypoglycaemia.西班牙1型糖尿病患者严重低血糖的成本以及赖脯胰岛素与常规人胰岛素相比在预防严重低血糖方面的成本效益
Int J Clin Pract. 2008 Jul;62(7):1026-32. doi: 10.1111/j.1742-1241.2008.01783.x. Epub 2008 May 16.
3
Model-based evaluation of diabetic foot prevention strategies in Austria.
奥地利糖尿病足预防策略的基于模型的评估。
Health Care Manag Sci. 2005 Nov;8(4):253-65. doi: 10.1007/s10729-005-4136-6.
4
Cost-of-illness studies in diabetes mellitus.糖尿病的疾病成本研究。
Pharmacoeconomics. 2004;22(3):149-64. doi: 10.2165/00019053-200422030-00002.
5
Selecting a decision model for economic evaluation: a case study and review.选择用于经济评估的决策模型:一个案例研究与综述
Health Care Manag Sci. 1998 Oct;1(2):133-40. doi: 10.1023/a:1019090401655.
6
Costs of diabetes. A methodological analysis of the literature.糖尿病的成本。文献的方法学分析。
Pharmacoeconomics. 1999 Jun;15(6):583-95. doi: 10.2165/00019053-199915060-00006.